Trial Profile
A 12-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2599506 in Patients With Type 2 Diabetes Mellitus Treated With Diet and Exercise, With or Without Metformin
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2022
Price :
$35
*
At a glance
- Drugs PSN 010 (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Jul 2022 This trial has been completed in Spain (End Date: 01 Jul 2010), according to European Clinical Trials Database record.
- 24 Jun 2010 Actual patient number (40) added as reported by ClinicalTrials.gov.
- 24 Jun 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.